ATE83150T1 - Etoposid-loesungen. - Google Patents

Etoposid-loesungen.

Info

Publication number
ATE83150T1
ATE83150T1 AT89116796T AT89116796T ATE83150T1 AT E83150 T1 ATE83150 T1 AT E83150T1 AT 89116796 T AT89116796 T AT 89116796T AT 89116796 T AT89116796 T AT 89116796T AT E83150 T1 ATE83150 T1 AT E83150T1
Authority
AT
Austria
Prior art keywords
etoposide
solutions
solution
dimethylisosorbide
formulated
Prior art date
Application number
AT89116796T
Other languages
English (en)
Inventor
Gururaj Bykadi
Murray A Kaplan
Richard G Corrao
Edward J Bara
Ismat Ullah
Shreeram Narahari Agharkar
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE83150T1 publication Critical patent/ATE83150T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT89116796T 1988-09-12 1989-09-11 Etoposid-loesungen. ATE83150T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions
EP89116796A EP0359184B1 (de) 1988-09-12 1989-09-11 Etoposid-Lösungen

Publications (1)

Publication Number Publication Date
ATE83150T1 true ATE83150T1 (de) 1992-12-15

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89116796T ATE83150T1 (de) 1988-09-12 1989-09-11 Etoposid-loesungen.

Country Status (14)

Country Link
US (1) US4927638A (de)
EP (1) EP0359184B1 (de)
JP (1) JPH02115126A (de)
KR (1) KR900004322A (de)
AT (1) ATE83150T1 (de)
AU (1) AU616049B2 (de)
DE (1) DE68903814T2 (de)
DK (1) DK446889A (de)
FI (1) FI894225A (de)
GR (1) GR3006501T3 (de)
IE (1) IE892898L (de)
IL (1) IL91598A0 (de)
PT (1) PT91682B (de)
ZA (1) ZA896916B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
EP0649651B1 (de) 1993-09-28 2000-12-13 R.P. Scherer GmbH Herstellung von Weichgelatinekapseln
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
WO1995029677A1 (en) * 1994-04-28 1995-11-09 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin or 7-ethyl camptothecin
EP0839029A1 (de) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stabile klare lösung von nicht-steroide anti-inflammatorischen arzneimitteln als zusatz in gelatinekapseln
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
WO2000044333A2 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Novel injectable antimalarial compositions of artemisinin
EP1289560A1 (de) * 2000-06-12 2003-03-12 SmithKline Beecham Corporation Neue feste dispersionszusammensetzungen
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
AU2007241593B2 (en) * 2006-04-24 2012-01-19 Bruce Medical Ab Polymer-based anti-cancer agents
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
CA2938974C (en) 2014-02-07 2023-08-22 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
PT91682B (pt) 1995-05-31
EP0359184B1 (de) 1992-12-09
DK446889D0 (da) 1989-09-11
DK446889A (da) 1990-03-13
AU616049B2 (en) 1991-10-17
GR3006501T3 (de) 1993-06-30
FI894225A (fi) 1990-03-13
AU4130189A (en) 1990-03-15
US4927638A (en) 1990-05-22
ZA896916B (en) 1991-08-28
FI894225A0 (fi) 1989-09-07
EP0359184A1 (de) 1990-03-21
JPH02115126A (ja) 1990-04-27
IE892898L (en) 1990-03-12
KR900004322A (ko) 1990-04-12
PT91682A (pt) 1990-03-30
IL91598A0 (en) 1990-04-29
DE68903814D1 (de) 1993-01-21
DE68903814T2 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
DE68903814D1 (de) Etoposid-loesungen.
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
NL940006I1 (nl) 1,2-Benzisoxyzol-3-yl- en 1,2-benzisothiazol-3-yl-derivaten
DK245087A (da) Triazolderivater samt herbicid indeholdende et saadant
DK673489D0 (da) Overtrukne klaebetabletter
KR880701201A (ko) 개방이 용이한 뚜껑이 달린 캔 및 그 제조방법
DK388686D0 (da) Formstofbeholder med et laag udformet med en taetsluttende laebe
DE68927925D1 (de) Supraleitender Transistor
DE3775981D1 (de) Kapseln.
DK470886D0 (da) Oxazol- og isoxazolderivater
DE68914113D1 (de) Kristallinische Form eines Farbstoffs und Herstellungsverfahren.
DK158598C (da) Penicillinpraeparat til rektal administration
FR2617528B1 (fr) Fermeture anti-panique a condamnation active
KR900002299U (ko) 해태제조기의 해태분사장치
DK620987A (da) Renin-inhibitorer med et lactam-pseudodipeptid
KR890006371U (ko) 포장침
IT8859013V0 (it) Progetto di sviluppo del metodo antifecondativo ogino knaus della contenzione periodica usando 1 termometro elettronico.
IT210056Z2 (it) Complesso per il supporto ed il contenimento di una macchina per cucire.
SE8601839D0 (sv) Kapsel med mjukt lock
SE8603009D0 (sv) Anordning for metning av deformationer i ett foremal
ES1008162Y (es) Chupete con efectos terapeuticos:
DK164221C (da) Gassifikationsproces
RO82025A2 (ro) Medicament vasodilatator si antihistaminic
SE8801619D0 (sv) Processor/processteknik for tillverkning av cellulosapellets
SE8702425D0 (sv) Engangsnappflaska med vellingpulver i forpackning

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee